Novel mouse tail intravenous injection needle, manufacturing method thereof and experimental application
A tail vein injection and needle technology, applied in the field of new mouse tail vein injection needles and its manufacture, can solve the problems of puncturing the tail vein, easy slipping out, and reducing the range of twisting the body
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0026] Such as figure 1 A novel mouse tail vein injection needle shown includes a needle body 1, and the needle body 1 is fixedly connected with a thin sheet 2, and the thin sheet 2 is folded and pressed and fixed on the needle body, and a shape about the needle body is formed on the needle body. The left and right symmetrical square side wings 3 of the needle body, one end of the side wing 3 is located at the midpoint of the needle body 1 , and the other end is located at the bottom of the needle body 1 .
[0027] In this embodiment, the length of the side wings 3 is 50% of the length of the needle body, and according to actual needs, it is between 45% and 55%, preferably 50%. Within this ratio range, it can effectively ensure the smooth insertion of the needle .
[0028] In this embodiment, the width of the left and right ends of the wing 3 is 2mm, of course, it can fluctuate between 1.9-2.1mm according to actual needs, preferably 2mm.
[0029] In this embodiment, the shee...
Embodiment 2
[0031] Using the novel mouse tail vein injection needle mentioned in Example 1 to carry out breast cancer cell metastasis experiment on mutant mice, the specific operation steps are as follows:
[0032] 1) Divide 32 female SPF Scid mice into two groups of CON and MU, 16 in each group, weighing 14-16g, and cut their ears respectively for marking.
[0033] 2) The human breast cancer cell line MDA-MB-231 and its mutant cell line MDA-MB-231MU were respectively configured as 5×10 6 / ml of cell suspension.
[0034] 3) Inject 0.2ml of MDA-MB-231 cell suspension into the tail vein of each CON group mouse, among which, 8 mice are injected with a disposable 1ml syringe with a traditional medical 25G injection needle, and the other 8 mice are injected with a disposable 1ml syringe Inject with a new type of needle, record the injection time (unit: s) of each mouse, and compare the twisting range of the mouse body and the success rate of injection when the two needles are injected.
[00...
Embodiment 3
[0046] Using the novel mouse tail vein injection needle mentioned in Example 1 to carry out breast cancer cell metastasis experiment on mutant mice, the specific operation steps are as follows:
[0047]1) Divide 32 female nude mice of SPF grade into two groups of CON and MU, with 16 mice in each group, weighing 14-16g, and cut their ears respectively for marking.
[0048] 2) The human breast cancer cell line MCF-7 and its mutant cell line MCF-7MU were respectively configured as 8×10 6 / ml of cell suspension.
[0049] 3) Each mouse in the CON group was injected with 0.2ml of MCF-7 cell suspension into the tail vein, 8 of them were injected with a disposable 1ml syringe with a traditional medical 25G injection needle, and the other 8 were injected with a disposable 1ml syringe with a new For needle injection, the injection time (unit: s) of each mouse was recorded respectively, and the twisting range of the mouse body and the success rate of bolus injection were compared betwee...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com